Mass market
and samples

Mass market
and samples

MetP’s filling unit Maxima

  • produces in accordance with industry standards for the mass market
  • complies with ISO and GMP standards and is certified
  • is at your disposal, pilot samples can be produced

Of highest ability

Since our MetP’s technology meets highest standards, the production line must also be of utmost quality and ability. Therefore, we chose to work with the most excellent design and engineering specialists.

The power of Maxima

Maxima complies with ISO and GMP standards and is certified. And most importantly: Maxima is capable to produce 50 million mono-dose devices per year – perfectly able to serve mass market.

Pilot samples for testing

To extend our R&D and pharmaceutical development, also to support clinical studies, it is necessary to have pilot samples. Since 2012 we produce these samples with the precursor of Maxima. It is possible to produce 5’000 samples per day. Please ask us regarding your requests concerning your molecules.

We have the capacity to produce 5’000 samples per day.

Please ask us regarding your requests concerning your molecules.

Claudia Mattern, CSO
Udo Mattern, CEO
Phone +41-41-618 30 30
Email

Summary

At MetP Pharma AG, we are capable to produce up to 50 million mono-dose devices per year. Also, pilot samples containing your drug molecule can be produced quickly, for R&D or clinical studies, either by using Maxima or our prototype system. Read more about our MetP's OTC and drug products or about our business and our story.

Udo Mattern CEO and chairman MetP Pharma AG

«200 applicators per minute – you stand at the production unit Maxima, and you are simply impressed.»

Udo Mattern CEO and chairman MetP Pharma AG